89353-92-4 Usage
Uses
Used in Chemical Synthesis:
(4Z,6S,7R)-7-bromo-4,6,8-trichloro-2,6-dimethylocta-1,4-dien-3-one is used as a synthetic intermediate for the creation of other organic compounds. The presence of bromine and chlorine atoms in its structure suggests potential reactivity in organic synthesis, allowing for the development of new molecules with specific functions and properties.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (4Z,6S,7R)-7-bromo-4,6,8-trichloro-2,6-dimethylocta-1,4-dien-3-one is used as a starting material for drug discovery and development. Its unique molecular structure and the presence of various functional groups make it a valuable compound for exploring new therapeutic agents and potential treatments for various diseases.
Used in Solubility Studies:
(4Z,6S,7R)-7-bromo-4,6,8-trichloro-2,6-dimethylocta-1,4-dien-3-one's methyl groups may contribute to its solubility and physical properties, making it useful in studies related to solubility and the development of more effective drug delivery systems.
Overall, (4Z,6S,7R)-7-bromo-4,6,8-trichloro-2,6-dimethylocta-1,4-dien-3-one is a versatile chemical compound with diverse potential applications in the field of chemistry and pharmaceutical research, including chemical synthesis, pharmaceutical research, and solubility studies.
Check Digit Verification of cas no
The CAS Registry Mumber 89353-92-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,3,5 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 89353-92:
(7*8)+(6*9)+(5*3)+(4*5)+(3*3)+(2*9)+(1*2)=174
174 % 10 = 4
So 89353-92-4 is a valid CAS Registry Number.
89353-92-4Relevant academic research and scientific papers
Bucher, Cyril,Deans, Richard M.,Burns, Noah Z.
, p. 12784 - 12787 (2015)
Over 160 chiral vicinal bromochlorinated natural products have been identified; however, a lack of synthetic methods for the selective incorporation of halogens into organic molecules has hindered their synthesis. Here we disclose the first total synthesis and structural confirmation of isoplocamenone and plocamenone, as well as the first selective and scalable synthesis of the preclinical anticancer natural product halomon. The synthesis of these inter-halogenated compounds has been enabled by our recently developed chemo-, regio-, and enantioselective dihalogenation reaction.
